These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma. Maricq HR Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525 [TBL] [Abstract][Full Text] [Related]
28. Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud's syndrome. Ferraccioli G; Di Poi E; Di Gregorio F; Giacomuzzi F; Guerra U Lancet; 1999 Dec 18-25; 354(9196):2135-6. PubMed ID: 10609825 [TBL] [Abstract][Full Text] [Related]
29. [Raynaud's phenomenon in the tongue of a patient with sclerodermia]. Klemp P; Staberg B; Thomsen K Ugeskr Laeger; 1983 Jan; 145(5):333. PubMed ID: 6845496 [No Abstract] [Full Text] [Related]
31. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon. Gastaud M; Dolisi C; Bermon S; Gaudin P; Defauw G; Ardisson JL Clin Exp Rheumatol; 1995; 13(5):617-21. PubMed ID: 8575140 [TBL] [Abstract][Full Text] [Related]
32. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends]. Zelli GP; Cannata P Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317 [No Abstract] [Full Text] [Related]
33. A study of headaches and migraine in Sjögren's syndrome and other rheumatic disorders. Pal B; Gibson C; Passmore J; Griffiths ID; Dick WC Ann Rheum Dis; 1989 Apr; 48(4):312-6. PubMed ID: 2712611 [TBL] [Abstract][Full Text] [Related]
34. Raynaud's phenomenon: its relevance to scleroderma. Belch JJ Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):839-45. PubMed ID: 1750795 [No Abstract] [Full Text] [Related]
35. Adverse effects of stellate ganglion block on Raynaud's phenomenon associated with progressive systemic sclerosis. Omote K; Kawamata M; Namiki A Anesth Analg; 1993 Nov; 77(5):1057-60. PubMed ID: 8214705 [No Abstract] [Full Text] [Related]
36. Artifactual hypoglycaemia in a patient with scleroderma and Raynaud's phenomenon. Osman R; Erasmus E; Lahri S; Moosajee F S Afr Med J; 2021 Feb; 111(2):13202. PubMed ID: 33944714 [No Abstract] [Full Text] [Related]
37. [Idiopathic and secondary Raynaud's phenomenon. A comparative psychosomatic approach]. Bayle O; Consoli SM; Baudin M; Vayssairat M; Fiessinger JN; Housset E Presse Med; 1990 Apr; 19(16):741-5. PubMed ID: 2140158 [TBL] [Abstract][Full Text] [Related]
38. Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma. Hummers LK; Wigley FM Rheum Dis Clin North Am; 2003 May; 29(2):293-313. PubMed ID: 12841296 [TBL] [Abstract][Full Text] [Related]
39. Increased pulmonary artery pressure in association with Raynaud's phenomenon. Ohar JM; Robichaud AM; Fowler AA; Glauser FL Am J Med; 1986 Aug; 81(2):361-2. PubMed ID: 3740093 [TBL] [Abstract][Full Text] [Related]
40. Raynaud's phenomenon with incomplete features of scleroderma: a wolf in sheep's clothing and a possible new indication for pulmonary/heart graft. Vayssairat M; Gouny P; Nussaume O Dermatology; 1994; 188(1):80. PubMed ID: 8305768 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]